Synthesis, biological activity and quantitative structure-activity relationships of N-substituted-3,4-dihydro-2H-1-benzopyran derivatives

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 10, 1996, Pages 1077-1082

  Marot, C ^a   Comoy, C ^a   Viaud, M C ^a   Rettori, M C ^b   Pfeiffer, B ^c   Morin Allory, L ^a   Guillaumet, G ^a  

^a UNIVERSITÉ D'ORLÉANS   (France)

^b INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^c ADIR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; BENZOPYRAN DERIVATIVE; DISULERGINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; GRANISETRON; KETANSERIN; RACLOPRIDE; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 1C RECEPTOR; SEROTONIN 1D RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 3 RECEPTOR;

ARTICLE; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG SYNTHESIS; MOLECULAR MODEL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RECEPTOR AFFINITY;

EID: 0029924720     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-894X(96)00174-6     Document Type: Article

References (23)

1. Johnston, A.; File, S. E. Pharmacol. Biochem. Behav. 1986, 24, 1457.
2. Eison, M. S. Psychopathology 1984, 17, 37.
3. Peroutka, S. J.; Snyder, S. H. J. Pharmacol. Exp. Ther. 1981, 216, 142.
4. Norman, A. B.; Battaglia, G.; Morrow, A. L.; Creese, I. Eur. J. Pharmacol. 1984, 106, 461.
5. Arvidsson, L. E.; Hacksell, U.; Nilsson, J. L. G.; Hjorth, S.; Carlsson, A.; Lindberg, P.; Sanchez, D.; Wikström, H. J. Med. Chem. 1981, 24, 921.
6. Middlemiss, D.; Fozard, J. R. Eur. J. Pharm. 1983, 90, 151.
7. Traber, J.; Glaser, T. Trends Pharmacol. Sci. 1987, 8, 422.
8. a) Fozard, J. R.; Mir, K. A.; Middlemiss, D. N. J. Cardiovasc. Pharmacol. 1987, 9, 328.
9. b) Mc Call, R. B.; Pattel, B. N.; Harris, L. T. J. Pharmacol. Exp. Ther. 1987, 242, 1152.
10. c) Clement, M. E.; Mc Call, R. B. Brain Res. 1990, 525, 232.
11. Podona, T.; Guardiola-Lemaître, B.; Caignard, D. H.; Adam, G.; Pfeiffer, B.; Renard, P.; Guillaumet, G. J. Med. Chem. 1994, 37, 1779.
12. Comoy, C.; Guillaumet, G. Heterocyclic Commun., in press.
13. Comoy, C.; Marot, C.; Podona, T.; Baudin, M. L.; Morin-Allory, L.; Guillaumet, G.; Pfeiffer, B.; Caignard, D. H.; Renard, P.; Rettori, M. C.; Adam, G.; Guardiola-Lemaître, B. J. Med. Chem. submitted for publication.
14. Wise, L. D.; DeWald, H. A.; Hawkins, E. S.; Reynolds, D. M.; Heffner, T. G.; Meltzer, L. T.; Pugsley, T. A; J. Med. Chem. 1988, 31, 688.
15. 1H-NMR, IR, mass spectra and elemental analysis data, in full agreement with their assigned structures.
16. 4) C, H, N.
17. 3 are respectively between 3.4-5.8 and 3.5-4.8.
18. Good, A. C.; Peterson, S. J.; Richards, W. G. J. Med. Chem. 1993, 36, 2929.
19. Mellin, C.; Vallgarda, J.; Nelson, D. L.; Björk, L.; Yu, H.; Anden, N. E.; Csöregh, I.; Arvidsson, L. E.; Hacksell, U. J. Med. Chem. 1991, 34, 497.
20. Hibert, M. F.; McDermott, I.; Middlemiss, D. N.; Mir, A. K.; Fozard, J. R. J. Med. Chem. 1988, 31, 1087.
21. Wold, S.; Ruhe, A.; Dunn, W. SIAM J. Sci. Statist. Comput. 1984, 5, 735.
22. Oxford Molecular Ltd, The Magdalen Center, Oxford Science Park, Sandford on Thames, Oxford OX4 4GA, United Kingdom.
23. Kubinyi, H. QSAR : Hansch Analysis and Related Approaches, Vol. 1, pp. 149-177, Mannhold, R.; Krogsgaard-Larsen, P.; Timmerman, H., Ed.; VCH; New York, 1993.